Literature DB >> 22691791

Crystallization and preliminary crystallographic study of a trypsin-resistant catalytic domain of human calcineurin.

Lei Jin1, Michael H A Roehrl, Li Xiao, Xiuyun He, Haibin Li, Linhu Ge, Bingyi Shi.   

Abstract

Calcineurin, a Ca(2+)/calmodulin-dependent serine/threonine protein phosphatase, plays a key role in a number of cellular pathways, including T-cell activation, and is an important molecular target of the immunosuppressive drugs cyclosporin A and FK506. To understand the structural basis underlying the activation of calcineurin by calmodulin, X-ray crystallography was employed to solve the three-dimensional structure of the free calcineurin catalytic domain (residues 20-347 of the A subunit). To accomplish this, a bacterially expressed glutathione S-transferase (GST) fusion protein of the human calcineurin catalytic domain was first purified by GST-affinity chromatography. After limited digestion by trypsin, the catalytic domain (Cncat) was purified using anion-exchange and size-exclusion chromatography. Crystallization of Cncat was achieved by the hanging-drop vapour-diffusion method at pH 6.5 using PEG 6000 as precipitant. The diffraction results showed that the Cncat crystal belonged to the orthorhombic space group P2(1)2(1)2, with unit-cell parameters a = 161.6, b = 87.4, c = 112.0 Å. There are four Cncat molecules in the asymmetric unit, with 49.5% solvent content. An X-ray diffraction data set was collected to 2.87 Å resolution and a clear molecular-replacement solution was obtained. The active site of Cncat is open to the solvent channels in the crystal packing.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22691791      PMCID: PMC3374516          DOI: 10.1107/S1744309112007890

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  22 in total

1.  Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A.

Authors:  J Aramburu; M B Yaffe; C López-Rodríguez; L C Cantley; P G Hogan; A Rao
Journal:  Science       Date:  1999-09-24       Impact factor: 47.728

Review 2.  Calcineurin: from structure to function.

Authors:  J Aramburu; A Rao; C B Klee
Journal:  Curr Top Cell Regul       Date:  2000

Review 3.  Unraveling hot spots in binding interfaces: progress and challenges.

Authors:  Warren L DeLano
Journal:  Curr Opin Struct Biol       Date:  2002-02       Impact factor: 6.809

4.  Discovering novel ligands for macromolecules using X-ray crystallographic screening.

Authors:  V L Nienaber; P L Richardson; V Klighofer; J J Bouska; V L Giranda; J Greer
Journal:  Nat Biotechnol       Date:  2000-10       Impact factor: 54.908

5.  Selective inhibition of calcineurin-NFAT signaling by blocking protein-protein interaction with small organic molecules.

Authors:  Michael H A Roehrl; Sunghyun Kang; José Aramburu; Gerhard Wagner; Anjana Rao; Patrick G Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-06       Impact factor: 11.205

6.  FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin.

Authors:  S J O'Keefe; J Tamura; R L Kincaid; M J Tocci; E A O'Neill
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

7.  Identification of calcineurin as a key signalling enzyme in T-lymphocyte activation.

Authors:  N A Clipstone; G R Crabtree
Journal:  Nature       Date:  1992-06-25       Impact factor: 49.962

8.  Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.

Authors:  Lei Jin; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-30       Impact factor: 11.205

9.  Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).

Authors:  Yoshiyasu Baba; Nozomu Hirukawa; Naoto Tanohira; Mikiko Sodeoka
Journal:  J Am Chem Soc       Date:  2003-08-13       Impact factor: 15.419

10.  Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes.

Authors:  Qing Huai; Hwa-Young Kim; Yudong Liu; Yingdong Zhao; Angelo Mondragon; Jun O Liu; Hengming Ke
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.